AstraZeneca Pharma India opens new Mumbai corporate office
Article excerpt
Highlighted: the sentence this signal was extracted from
*this image is generated using AI for illustrative purposes only. AstraZeneca Pharma India Limited inaugurated a new 25,600 sq ft corporate office in Mumbai on October 16, 2026. The facility marks an extension of the company's presence in India, reinforcing its ambition to transform care by unlocking the power of science. The new office was inaugurated by Maharashtra Chief Minister Devendra Fadnavis alongside senior government officials and embassy dignitaries. This strategic move aims to strengthen the company's ability to work with partners across the healthcare ecosystem and advance solutions for patients in India. AstraZeneca has introduced more than 25 new medicines and indications in India over the past three years. The company is currently running about 80 global clinical trials in the country. These efforts support the development of new treatments and strengthen India's contribution to global research. Praveen Rao Akkinepally, Country President and Managing Director, stated that India is at an important inflection point in healthcare with a growing need for earlier diagnosis and innovative treatments. The company employs nearly 5,000 colleagues across the country. The organization focuses on pioneering newer access pathways so life-saving therapies reach every patient. Working closely with governments and industry, AstraZeneca leverages AI and builds solutions...
Keep reading with a free account
The rest of this article, and every signal for AstraZeneca, is in your free account.
